TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients

NCT05434312 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myelogenous Leukemia

Interventions

DRUG: TGRX-678

Sponsor

Shenzhen TargetRx Co., Ltd.

Collaborators

[object Object]